Greenwich LifeSciences (GLSI) Stock: Buy, Sell, or Hold?
GLSI - Greenwich LifeSciences, Inc.
$15.63
-0.46 (-2.86%)
âŧ
5d:
+3.99%
30d:
-10.07%
90d:
-34.55%
WAIT
LOW Confidence
Analysis Updated: Sep 16, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When GLSI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: GLSI is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: GLSI is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: GLSI is currently trading at $15.63, which is considered slightly low relative to its 30-day fair value range of $15.22 to $17.40.
Technical Outlook: Technically, GLSI is in a strong downtrend. Immediate support is located at $14.46, while resistance sits at $16.43.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $57.00 (+264.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GLSI is in a strong downtrend. Immediate support is located at $14.46, while resistance sits at $16.43.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $57.00 (+264.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$15.22 -
$17.40
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (50/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 264.7% below Wall St target ($57.00)
- WARNING: Composite score 42/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$15.22 -
$17.40
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$14.46
Resistance Level
$16.43
Current Trend
Strong Downtrend
Technical data as of
Sep 16, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-13.36
Wall Street Target
$57.00
(+264.7%)
Share & Embed Analysis
Last updated: September 17, 2026 2:03 AM ET
Data refreshes hourly during market hours. Next update: 3:03 AM
Data refreshes hourly during market hours. Next update: 3:03 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GLSI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$432 | 62 BUY |
|
ALNY
Alnylam Pharmaceuticals âĻ |
STRONG BUY
30 analysts |
$371 | 42 HOLD |
|
VRTX
Vertex Pharmaceuticals IâĻ |
BUY
34 analysts |
$569 | 42 HOLD |
|
CLDX
Celldex Therapeutics Inc |
STRONG BUY
15 analysts |
$59 | 64 BUY |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$314 | 48 HOLD |
